98370905 - MYOPEPDYS (VESLETEPLIRSEN) INJECTION

Information

• Trademark
• 98370905

• Source

• Serial Number

  98370905

• International Classifications

  • 5 - Pharmaceutical and veterinary preparations
  • 41 - Education
  • 44 - Medical services

• Filing Date

  January 23, 2024
  a year ago

• Transaction Date

  July 01, 2025
  4 months ago

• Status Date

  June 30, 2025
  4 months ago

• Published for Opposition Date

  October 01, 2024
  a year ago

• Location Date

  November 26, 2024
  11 months ago

• Status Code

  606

• Current Location

  INTENT TO USE SECTION

  Employee Name

  MICHELI, ANGELA

• Attorney Name

  Maury M. Tepper, III

  Law Office Assigned Location Code

  L10

• Owners

  • SAREPTA THERAPEUTICS, INC.

Case File Statements

• GS0411: Medical training and teaching
• DM0000: The mark consists of two stylized open-shaped polygons, slightly juxtaposed and facing one another that together form a stylized hexagon; the polygon on the left faces to the upper right and consists of five segments and the polygon on the right faces to the lower left and consists of four segment. The word MYOPEPDYS is to the right of the polygons and the term '(vesleteplirsen) injection' is below MYOPEPDYS. Color is not claimed as a feature of the mark.
• GS0051: Pharmaceutical preparations for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Pharmaceutical preparations based on morpholino oligomer technology platform for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders, and for the regulation of protein production; Pharmaceutical preparations that modulate RNA expression for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders, and for the regulation of protein production; Gene therapy products, namely, gene delivery pharmaceuticals; Pharmaceutical preparations for gene therapy, gene editing, and genome editing; Gene therapy products in the nature of pharmaceuticals for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Biological preparations for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Viruses, viral vectors and viral constructs for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Pharmaceutical preparations, biological preparations and gene therapy products in the nature of pharmaceutical and biological preparations for the treatment of genetic disorders and diseases
• CC0000: Color is not claimed as a feature of the mark.
• GS0441: Medical services; providing health information
• DS0000: "VESLETEPLIRSEN INJECTION"

Case File Event Statements

• 1/23/2024 - a year ago

  1 - NEW APPLICATION ENTERED Type: NWAP

• 5/28/2024 - a year ago

  3 - NOTICE OF DESIGN SEARCH CODE E-MAILED Type: MDSC

• 5/28/2024 - a year ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 8/19/2024 - a year ago

  4 - ASSIGNED TO EXAMINER Type: DOCK

• 8/23/2024 - a year ago

  8 - EXAMINER'S AMENDMENT ENTERED Type: XAEC

• 8/23/2024 - a year ago

  5 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA

• 8/23/2024 - a year ago

  7 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN

• 8/23/2024 - a year ago

  9 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 8/23/2024 - a year ago

  6 - EXAMINERS AMENDMENT E-MAILED Type: GNEA

• 9/11/2024 - a year ago

  10 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP

• 10/1/2024 - a year ago

  11 - PUBLISHED FOR OPPOSITION Type: PUBO

• 10/1/2024 - a year ago

  12 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB

• 11/26/2024 - 11 months ago

  13 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM

• 6/30/2025 - 4 months ago

  14 - ABANDONMENT - NO USE STATEMENT FILED Type: ABN6

• 6/30/2025 - 4 months ago

  15 - ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Type: MAB6